Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM GLBZ
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM GLBZ
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.0M
operating cash flow minus capex, 2024-10-01 to 2025-09-30
Free cash flow, TTM GLBZ
FY Dec 2024
-$53.0K
FY Dec 2023
$1.2M
FY Dec 2022
$2.0M
FY Dec 2021
$3.4M
FY Dec 2020
$1.0M
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
-$678.0K
Sep 2024
$513.0K
Jun 2024
$27.0K
Mar 2024
$85.0K
Dec 2023
$547.0K
At each fiscal year end
Single quarter
Debt to equity
1.11x
long-term 2022-06-30 (39 months older than the period end) plus current 2025-06-30; equity 2025-09-30
Debt to equity GLBZ
FY Dec 2024
2.25x
FY Dec 2023
2.07x
FY Dec 2022
1.87x
FY Dec 2021
0.56x
FY Dec 2020
0.81x
Sep 2025
1.11x
Jun 2025
1.21x
Mar 2025
1.56x
Dec 2024
2.25x
Sep 2024
1.89x
Jun 2024
2.29x
Mar 2024
2.76x
Dec 2023
2.07x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.08x
TTM operating cash flow over long-term 2022-06-30 (39 months older than the period end) plus current 2025-06-30
Cash flow to debt GLBZ
FY Dec 2024
0.00x
FY Dec 2023
0.03x
FY Dec 2022
0.07x
FY Dec 2021
0.18x
FY Dec 2020
0.05x
Sep 2025
-0.08x
Jun 2025
-0.03x
Mar 2025
-0.02x
Dec 2024
0.00x
Sep 2024
0.03x
Jun 2024
0.02x
Mar 2024
0.03x
Dec 2023
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+0.1%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on equity GLBZ
FY Dec 2024
-0.6%
FY Dec 2023
+8.1%
FY Dec 2022
+6.7%
FY Dec 2021
+6.9%
FY Dec 2020
+4.6%
Sep 2025
+0.1%
Jun 2025
+0.2%
Mar 2025
+0.2%
Dec 2024
-0.6%
Sep 2024
+0.6%
Jun 2024
+3.0%
Mar 2024
+5.5%
Dec 2023
+8.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.0%
TTM net income over average of 2024-09-30 and 2025-09-30
Return on assets GLBZ
FY Dec 2024
-0.0%
FY Dec 2023
+0.4%
FY Dec 2022
+0.4%
FY Dec 2021
+0.6%
FY Dec 2020
+0.4%
Sep 2025
+0.0%
Jun 2025
+0.0%
Mar 2025
+0.0%
Dec 2024
-0.0%
Sep 2024
+0.0%
Jun 2024
+0.1%
Mar 2024
+0.3%
Dec 2023
+0.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GLBZ
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GLBZ
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing GLBZ
FY Dec 2024
n/a
FY Dec 2023
12.00x
FY Dec 2022
13.62x
FY Dec 2021
15.91x
FY Dec 2020
18.64x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
186.67x
Jun 2024
22.00x
Mar 2024
15.66x
Dec 2023
12.00x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$23.2M
market value at close 2026-10-27 on 2025-11-04 shares, plus long-term 2022-06-30 (39 months older than the period end) plus current 2025-06-30, minus cash 2025-09-30
Enterprise value GLBZ
FY Dec 2024
$32.4M
FY Dec 2023
$42.0M
FY Dec 2022
$23.7M
FY Dec 2021
$28.5M
FY Dec 2020
$34.1M
Sep 2025
$24.3M
Jun 2025
$24.9M
Mar 2025
$21.0M
Dec 2024
$32.4M
Sep 2024
$33.8M
Jun 2024
$34.7M
Mar 2024
$23.2M
Dec 2023
$42.0M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-16.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield GLBZ
FY Dec 2024
-0.3%
FY Dec 2023
+7.2%
FY Dec 2022
+8.3%
FY Dec 2021
+8.4%
FY Dec 2020
+3.3%
Sep 2025
-15.0%
Jun 2025
-4.6%
Mar 2025
-4.0%
Dec 2024
-0.3%
Sep 2024
+7.2%
Jun 2024
+6.8%
Mar 2024
+7.2%
Dec 2023
+7.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing GLBZ
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.32x
FY Dec 2020
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GLBZ ranks highest on risk and compliance (95th percentile) and profitability (8th), and lowest on financial health (6th), among Banks peers.
Profitability
8
Inputs
Return on equity+0.1% · 8 pct, sector of 327
Return on assets+0.0% · 7 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
6
Inputs
Debt to equity1.11x · 7 pct, sector of 229
Cash flow to debt-0.08x · 5 pct, sector of 198
Risk and compliance
95
Inputs
Short interest, % of float+0.0% · 95 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Growth, Insider conviction, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.